1. Afatinib in the treatment of breast cancer. (July 2014) Authors: Hurvitz, Sara A; Shatsky, Rebecca; Harbeck, Nadia Journal: Expert opinion on investigational drugs Issue: Volume 23:Number 7(2014:Jul.) Page Start: 1039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Afatinib in the treatment of breast cancer. (July 2014) Authors: Hurvitz, Sara A; Shatsky, Rebecca; Harbeck, Nadia Journal: Expert opinion on investigational drugs Issue: Volume 23:Number 7(2014:Jul.) Page Start: 1039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibody-Drug Conjugates : Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer /: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer. (2016) Editors: Olivier, Kenneth J; Hurvitz, Sara A Record Type: Book Extent: 1 online resource (560 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial. Issue 7 (July 2015) Authors: Hurvitz, Sara A; Andre, Fabrice; Jiang, Zefei; Shao, Zhimin; Mano, Max S; Neciosup, Silvia P; Tseng, Ling-Min; Zhang, Qingyuan; Shen, Kunwei; Liu, Donggeng; Dreosti, Lydia M; Burris, Howard A; Toi, Masakazu; Buyse, Marc E; Cabaribere, David; Lindsay, Mary-Ann; Rao, Shantha; Pacaud, Lida Bubuteish... Journal: Lancet oncology Issue: Volume 16:Issue 7(2015:Jul.) Page Start: 816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dose intensification of chemotherapy for early breast cancer in the age of de-escalation. Issue 10179 (6th April 2019) Authors: Hurvitz, Sara A Journal: Lancet Issue: Volume 393:Issue 10179(2019) Page Start: 1390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study. Issue 2 (22nd July 2020) Authors: Huang, Chiun-Sheng; Yu, Alice L; Tseng, Ling-Ming; Chow, Louis W C; Hou, Ming-Feng; Hurvitz, Sara A; Schwab, Richard B; L Murray, James; Chang, Hsien-Kun; Chang, Hong-Tai; Chen, Shin-Cheh; Kim, Sung-Bae; Hung, Jung-Tung; Ueng, Shir-Hwa; Lee, Su-Hua; Chen, Chwen-Cheng; Rugo, Hope S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HER2DX: a tool that might inform treatment choices for HER2-positive breast cancer. Issue 11 (November 2020) Authors: Hurvitz, Sara A Journal: Lancet oncology Issue: Volume 21:Issue 11(2020) Page Start: 1392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Is the duration of adjuvant trastuzumab debate still clinically relevant?. Issue 10191 (29th June 2019) Authors: Hurvitz, Sara A Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial. Issue 1 (January 2018) Authors: Hurvitz, Sara A; Martin, Miguel; Symmans, W Fraser; Jung, Kyung Hae; Huang, Chiun-Sheng; Thompson, Alastair M; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-François; Beckmann, Matthias W; Afenjar, Karen; Fresco, Rodrigo; Helms, Hans-Joachim... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. New directions in the neoadjuvant treatment of HER2+ breast cancer. (September 2015) Authors: Hobbs, Evthokia A; Hurvitz, Sara A Journal: Breast cancer management Issue: Volume 4:Number 4(2015) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗